Analytica Therapeutics

Analytica Therapeutics is an early-stage biotechnology company based in San Diego, California, focused on developing novel small molecule therapeutics for oncology. The company specializes in targeting the Hippo signaling pathway, specifically developing inhibitors of LATS1/2 kinases to modulate the activity of YAP/TAZ transcriptional coactivators. By restoring control over this critical pathway, Analytica aims to address various solid tumors where Hippo signaling is dysregulated, including mesothelioma and cancers of the liver and breast. The company operates primarily in a stealth or early-development mode, leveraging expertise in medicinal chemistry and cancer biology to advance its pipeline of Hippo-targeted agents.